Generation of dopaminergic neurons from human fetal mesencephalic progenitors after co-culture with striatal-conditioned media and exposure to lowered oxygen

Brain Research Bulletin

Volumn 80, Issue 1-2, 2009, Pages 62-68

  Liu, Shuang ^a,b   Tian, Zengmin ^a   Yin, Feng ^a   Zhao, Quanjun ^a   Fan, Ming ^b  

^a NAVY GENERAL HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Lowered oxygen; Mesencephalic progenitors; Striatal conditioned media; Tyrosine hydroxylase positive neurons

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; ERYTHROPOIETIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; NUCLEAR RECEPTOR RELATED FACTOR 1; OXYGEN; POTASSIUM ION; PROTEIN P27; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PITX3; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; CELL HYPOXIA; CELL MATURATION; CELL STRUCTURE; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DEPOLARIZATION; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; EMBRYO; EMBRYONIC STEM CELL; FETUS; FETUS CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCEPHALON; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; PRIORITY JOURNAL; STRIATE CORTEX;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DOPAMINE; FETUS; HUMANS; MESENCEPHALON; NEURONS; OXYGEN; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS; TYROSINE 3-MONOOXYGENASE;

EID: 67650604363     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2009.05.007     Document Type: Article

References (32)

1. Bjorklund A., and Lindvall O. Dopamine-containing systems in the CNS. In: Bjorklund A., and Hokfelt T. (Eds). Handbook of Chemical Neuroanatomy Classical Transmitters in the CNS vol. 2 (1984), Elsevier Science Publishers, Amsterdam 55-111
2. Yasuhara T., Shingo T., Muraoka K., Wen Ji Y., Kameda M., Takeuchi A., Yano A., Nishio S., Matsui T., Miyoshi Y., Hamada H., and Date I. Neurorescue effects of VEGF on a rat model of Parkinson's disease. Brain Res. 1053 (2005) 10-18
3. Clarkson E.D., Zawada W.M., and Freed C.R. GDNF reduces apoptosis in dopaminergic neurons in vitro. Neuroreport 7 (1995) 145-149
4. Ferriero D.M. Protecting neurons. Epilepsia 46 (2005) 45-51
5. Freeman T.B., Vawter D.E., Leaverton P.E., Godbold J.H., Hauser R.A., Goetz C.G., and Olanow C.W. Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. N. Engl. J. Med. 341 (1999) 988-992
6. Greenberg D.A., and Jin K. From angiogenesis to neuropathology. Nature 438 (2005) 954-959
7. Gundersen R.W. Interference reflection microscopic study of dorsal root growth cones on different substrates: assessment of growth cone-substrate contacts. J. Neurosci. Res. 21 (1988) 298-306
8. Ikemoto S. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res. Rev. 56 (2007) 27-78
9. Johe K.K., Hazel T.G., Muller T., Dugich-Djordjevic M.M., and McKay R.D. Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes Dev. 10 (1996) 3129-3140
10. Junk A.K., Mammis A., Savitz S.I., Singh M., Roth S., Malhotra S., Rosenbaum P.S., Cerami A., Brines M., and Rosenbaum D.M. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 10659-10664
11. Kim J.H., Auerbach J.M., Rodríguez-Gómez J.A., Velasco I., Gavin D., Lumelsky N., Lee S.H., Nguyen J., Sánchez-Pernaute R., Bankiewicz K., and McKay R. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418 (2002) 50-56
12. Kocsis J.D., Akiyama Y., and Radtke C. Neural precursors as a cell source to repair the demyelinated spinal cord. J. Neurotrauma 21 (2004) 441-449
13. Koff A., and Polyak K. p27KIP1, an inhibitor of cyclin dependent kinases. Prog. Cell Cycle Res. 1 (1995) 141-147
14. Kosaka T., Kosaka K., Hataguchi Y., Nagatsu I., Wu J.Y., Ottersen O.P., Storm-Mathisen J., and Hama K. Catecholaminergic neurons containing GABA-like and/or glutamic acid decarboxylase-like immunoreactivities in various brain regions of the rat. Exp. Brain Res. 66 (1987) 191-210
15. Lee S.H., Lumelsky N., Studer L., Auerbach J.M., and McKay R.D. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol. 18 (2000) 675-679
16. Lindvall O., Kokaia Z., and Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med. 10 Suppl. (2004) S42-S50
17. McBride J.L., Behrstock S.P., Chen E.Y., Jakel R.J., Siegel I., Svendsen C.N., and Kordower J.H. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J. Comp. Neurol. 475 (2004) 211-219
18. McKay R.D. Stem cells in the central nervous system. Science 276 (1997) 66-71
19. Nakamura Y., Ozaki T., Koseki H., Nakagawara A., and Sakiyama S. Accumulation of p27KIP1 is associated with BMP2-induced growth arrest and neuronal differentiation of human neuroblastoma-derived cell lines. Biochem. Biophys. Res. Commun. 307 (2003) 206-213
20. Ohyamal K., Ellis P., and Placzek S.K.M. Directed differentiation of neural cells to hypothalamic dopaminergic neurons. Development 132 (2005) 5185-5197
21. Olanow C.W., Kordower J.H., and Freeman T.B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19 (1996) 102-109
22. Olanow C.W., and Obeso J.A. Preventing levodopa-induced dyskinesias. Ann. Neurol. 47 (2000) 167-176
23. 2 and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells. J. Cell Sci. 119 (2006) 2667-2678
24. Panchision D., Hazel T., and McKay R. Plasticity and stem cells in the vertebrate nervous system. Curr. Opin. Cell Biol. 10 (1998) 727-733
25. Prasad A., and Reynolds J.N. Uncoupling of GABA-benzodiazepine receptors in chick cerebral cortical neurons requires co-activation of both receptor sites. Brain Res. 591 (1992) 327-331
26. Rolletschek A., Chang H., Guan K., Czyz J., Meyer M., and Wobus A.M. Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors. Mech. Dev. 105 (2001) 93-104
27. Rosenthal A. Auto transplants for Parkinson's disease?. Neuron 20 (1998) 169-172
28. Semenza G.L. Oxygen-regulated transcription factors and their role in pulmonary disease. Respir. Res. 1 (2000) 159-162
29. Studer L., Csete M., Lee S.H., Kabbani N., Walikonis J., Wold B., and McKay R. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J. Neurosci. 20 (2000) 7377-7383
30. Yan Y., Yang D., Zarnowska E.D., Du Z., Werbel B., Valliere C., Pearce R.A., Thomson J.A., and Zhang S.-C. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cell. Stem Cell 23 (2007) 781-790
31. Yasuhara T., Shingo T., Muraoka K., wen Ji Y., Kameda M., Takeuchi A., Yano A., Nishio S., Matsui T., Miyoshi Y., Hamada H., and Date I. Neurorescue effects of VEGF on a rat model of Parkinson's disease. Brain Res. 1053 (2005) 10-18
32. Yin F., Tian Z., Liu S., Zhao Q., and Li S. Local effects of dexamethasone on immune reaction in neural transplantation. Transpl. Immunol. 18 (2007) 126-129